1C
1315 Capital
Private EquityModerate1315 Capital provides expansion and growth capital to commercial stage pharmaceuticals, medical technologies, and healthcare services.
5
Investments
1
Exits
$1B
AUM
20.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for 1315 Capital.
Investment Thesis & Strategy
1315 Capital invests in commercial-stage companies within the pharmaceuticals, medical technologies, and healthcare services sectors, providing expansion and growth capital. They focus on companies that are ready to scale and have demonstrated commercial viability.
Investment Activity
Deals per year over the last 6 years
2
20163
20172
20183
20191
20201
2021Portfolio Companies
Selected investments from their portfolio of 5 companies
U
US Urology Partners
Healthcare · Growth, 2021
U
US Orthopedic Partners
Healthcare · Growth, 2020
U
US Endodontics Partners
Healthcare · Growth, 2019
V
Vascular Therapies
Healthcare · Growth, 2019
O
OrthoBethesda
Healthcare · Growth, 2019
M
MedPharm
Healthcare · Growth, 2018
U
US Oral Surgery Management
Healthcare · Growth, 2018
N
North American Dental Group
Healthcare · Growth, 2017
B
BioDelivery Sciences
Healthcare · Growth, 2017
B
BioPlus Specialty Pharmacy
Healthcare · Growth, 2017
M
MedData
Healthcare · Growth, 2016
U
US Anesthesia Partners
Healthcare · Growth, 2016
Frequently Asked Questions
1315 Capital focuses on Series B, Series C+ stage investments.
Related Investors
LLR Partners
Philadelphia, United States · 71 deals
Susquehanna Growth Equity
Philadelphia, United States · 60 deals
Mid Atlantic Angel Fund
Philadelphia, United States · 9 deals
Red & Blue Ventures
Philadelphia, United States · 8 deals
LL Funds
Philadelphia, United States · 7 deals
Patriot Financial Partners
Philadelphia, United States · 3 deals